semaglutide and optic neuropathy A recent VA study suggests that starting in patients with type 2 diabetes may be linked to a rare but increased risk of nonarteritic anterior ischemic (NAION) compared to Semaglutide linked to increased risk

Your gut bacteria ferment soluble fiber into short-chain fatty acids, and those short-chain fatty acids activate the receptors on your L-cells that stimulate GLP-1 release

Final Thoughts Getting weight loss drugs covered by insurance can feel like a frustrating maze, but the right guidance can make all the difference

They may contribute antioxidants and support an overall anti-inflammatory eating pattern

Eli Lilly Moves Closer to the Next Generation of Obesity Treatment Eli Lilly has announced positive Phase 3 results for retatrutide, its investigational triple-receptor agonist targeting GLP-1, GIP, and glucagon receptors